Table 2. Change in pfmdrl copy no. (CN) between pretreatment and posttreatment isolates after polymerase chain reaction–confirmed recrudescence.
| Pretreatment CN, posttreatment CN | Mefloquine | Mefloquine plus artesunate | Artemether-lumefantrine | Artemisinin monotherapya | Quinine |
|---|---|---|---|---|---|
| Single | |||||
| Single | 3 (33) | 3 (30) | 6 (75) | 10 (100) | 1 (50) |
| Increased | 6 (67) | 7 (70) | 2 (25) | 0 (0) | 1 (50) |
| Total | 9 | 10 | 8 | 10 | 2 |
|
| |||||
| Increased | |||||
| Increased | 22 (100) | 25 (96) | 17 (89) | 13 (81) | 6 (60) |
| Single | 0 (0) | 1 (3.8) | 2 (11) | 3 (19) | 4 (40) |
| Total | 22 | 26 | 19 | 16 | 10 |
NOTE. Data are no. (%) of isolates.
a
Artesunate or artemether at 12 mg/kg over 7 days.